Huaxia Eye Hospital Group Co.,Ltd.

SZSE:301267 Stock Report

Market Cap: CN¥17.5b

Huaxia Eye Hospital GroupLtd Future Growth

Future criteria checks 3/6

Huaxia Eye Hospital GroupLtd is forecast to grow earnings and revenue by 22.4% and 15.4% per annum respectively. EPS is expected to grow by 22.4% per annum. Return on equity is forecast to be 12.6% in 3 years.

Key information

22.4%

Earnings growth rate

22.4%

EPS growth rate

Healthcare earnings growth22.9%
Revenue growth rate15.4%
Future return on equity12.6%
Analyst coverage

Low

Last updated28 Oct 2024

Recent future growth updates

Recent updates

Is Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Expensive For A Reason? A Look At Its Intrinsic Value

Dec 23
Is Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Expensive For A Reason? A Look At Its Intrinsic Value

Here's What's Concerning About Huaxia Eye Hospital GroupLtd's (SZSE:301267) Returns On Capital

Oct 28
Here's What's Concerning About Huaxia Eye Hospital GroupLtd's (SZSE:301267) Returns On Capital

Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) 43% Price Boost Is Out Of Tune With Earnings

Sep 30
Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) 43% Price Boost Is Out Of Tune With Earnings

Huaxia Eye Hospital GroupLtd's (SZSE:301267) Conservative Accounting Might Explain Soft Earnings

Sep 04
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Conservative Accounting Might Explain Soft Earnings

Does Huaxia Eye Hospital GroupLtd (SZSE:301267) Have A Healthy Balance Sheet?

Aug 19
Does Huaxia Eye Hospital GroupLtd (SZSE:301267) Have A Healthy Balance Sheet?

Huaxia Eye Hospital GroupLtd's (SZSE:301267) Dividend Is Being Reduced To CN¥0.11

Jul 12
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Dividend Is Being Reduced To CN¥0.11

Huaxia Eye Hospital GroupLtd (SZSE:301267) Has Some Way To Go To Become A Multi-Bagger

Jun 06
Huaxia Eye Hospital GroupLtd (SZSE:301267) Has Some Way To Go To Become A Multi-Bagger

Analysts Just Shaved Their Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Forecasts Dramatically

May 01
Analysts Just Shaved Their Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Forecasts Dramatically

Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly

Feb 29
Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly

Earnings and Revenue Growth Forecasts

SZSE:301267 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265,972986N/A1,2474
12/31/20255,190828N/A1,0434
12/31/20244,652743N/A9555
9/30/20244,092529507910N/A
6/30/20244,070577515955N/A
3/31/20244,061672405867N/A
12/31/20234,013666513961N/A
9/30/20233,813674517880N/A
6/30/20233,648632510798N/A
3/31/20233,355552656872N/A
1/1/20233,233514535770N/A
9/30/20223,297516688871N/A
1/1/20223,064455624798N/A
9/30/20212,998445552731N/A
12/31/20202,515334427591N/A
12/31/20192,456218188444N/A
12/31/20182,146164-47291N/A
12/31/20171,54378N/A298N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 301267's forecast earnings growth (22.4% per year) is above the savings rate (2.8%).

Earnings vs Market: 301267's earnings (22.4% per year) are forecast to grow slower than the CN market (25.8% per year).

High Growth Earnings: 301267's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 301267's revenue (15.4% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 301267's revenue (15.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 301267's Return on Equity is forecast to be low in 3 years time (12.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:45
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huaxia Eye Hospital Group Co.,Ltd. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yichi ZhangChina International Capital Corporation Limited
null nullChina International Capital Corporation Limited
Shuo SongCitic Securities Co., Ltd.